Anacor Pharmaceuticals, Inc. (ANAC) Posts Q1 Loss of 42c/Share

May 9, 2013 4:46 PM EDT Send to a Friend
Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) reported Q1 EPS of ($0.42), $0.03 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.57 million.

For earnings history and earnings-related data on Anacor Pharmaceuticals, Inc. (ANAC) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment